Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | VYGR | ALVO | ||
| Company | Cybin Inc | Voyager Therapeut | Alvotech | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 3.0500 | 8.65 | 14.50 | ||
| High | 3.2000 | 8.65 | 14.56 | ||
| Low | 2.8736 | 8.27 | 14.44 | ||
| Last | 3.0200 | 8.53 | 14.51 | ||
| Change | -0.0400 | +0.17 | +0.03 | ||
| % Change | -1.31% | +2.03% | +0.21% | ||
| Volume | 864,300 | 435,800 | 231,600 | ||
| 20-Day Average Volume | 1,094,590 | 490,630 | 260,230 | ||
| Previous Close | 3.0600 | 8.36 | 14.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 8.14 | 13.09 | ||
| 20-Day Raw Stochastic | 71.64% | 59.07% | 93.00% | ||
| 20-Day Relative Strength | 62.45% | 51.36% | 60.62% | ||
| Weighted Alpha | +130.72 | -4.78 | +58.26 | ||
| Today's Opinion | N/A | 24% Buy | 72% Buy | ||
| Previous Opinion | N/A | 8% Buy | 72% Buy | ||
| Last Month's Opinion | N/A | 72% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +14.96% since 04/25/24 | +6.30% since 04/25/24 | ||
| Low | 2.7300 on 07/29/21 | 7.32 on 04/26/24 | 14.00 on 04/26/24 | ||
| High | 3.3800 on 08/02/21 | 8.65 on 05/02/24 | 14.76 on 04/30/24 | ||
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | -13.93% since 04/02/24 | +27.28% since 04/02/24 | ||
| Low | 2.1105 on 07/08/21 | 7.26 on 04/25/24 | 11.19 on 04/12/24 | ||
| High | 3.3800 on 08/02/21 | 9.72 on 04/03/24 | 14.76 on 04/30/24 | ||
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | +14.50% since 02/02/24 | -7.58% since 02/02/24 | ||
| Low | 1.3429 on 06/01/21 | 7.08 on 02/13/24 | 11.01 on 04/02/24 | ||
| High | 3.3800 on 08/02/21 | 10.66 on 04/01/24 | 18.00 on 02/26/24 | ||
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +32.25% since 11/02/23 | +63.03% since 11/02/23 | ||
| Low | 0.9500 on 03/30/21 | 6.06 on 11/13/23 | 8.39 on 11/08/23 | ||
| High | 3.3800 on 08/02/21 | 11.72 on 01/02/24 | 18.00 on 02/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 454,684 | 452,500 | ||
| Shares Outstanding, K | 148,598 | 54,388 | 31,250 | ||
| Annual Sales | 650,000 | 250,010,000 | 91,430,000 | ||
| Annual Net Income | -24,420,000 | 132,330,000 | -551,730,000 | ||
| Last Quarter Sales | N/A | 90,060,000 | 18,900,000 | ||
| Last Quarter Net Income | N/A | 56,400,000 | -276,560,000 | ||
| 60-Month Beta | N/A | 0.98 | -0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.25 on 02/28/24 | -1.22 on 03/20/24 | ||
| Latest Earnings Date | N/A | 05/14/24 | 05/17/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 2.53 | 0.00 | ||